Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome

BACKGROUND AND OBJECTIVES: Atypical hemolytic uremic syndrome is characterized by vascular endothelial damage caused by complement dysregulation. Consistently, complement inhibition therapies are highly effective in most patients with atypical hemolytic uremic syndrome. Recently, it was shown that a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Sánchez Chinchilla, Daniel, Pinto, Sheila, Hoppe, Bernd, Adragna, Marta, Lopez, Laura, Justa Roldan, Maria Luisa, Peña, Antonia, Lopez Trascasa, Margarita, Sánchez-Corral, Pilar, Rodríguez de Córdoba, Santiago
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Nephrology 2014
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4152807/
https://ncbi.nlm.nih.gov/pubmed/25135762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.01640214
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia